KK
RCUS icon

KLP Kapitalforvaltning’s Arcus Biosciences RCUS Stock Holding History

KLP Kapitalforvaltning’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Hold
19,300
– – ﹤0.01% 1435
2026
Q1 		$417K Buy
19,300
+1,100
+6% +$23.8K ﹤0.01% 1501
2025
Q4 		$434K Sell
18,200
-3,700
-17% -$75.5K ﹤0.01% 1482
2025
Q3 		$298K Hold
21,900
– – ﹤0.01% 1657
2025
Q2 		$178K Buy
21,900
+8,000
+58% +$68.3K ﹤0.01% 1831
2025
Q1 		$109K Hold
13,900
– – ﹤0.01% 1993
2024
Q4 		$207K Buy
+13,900
New +$227K ﹤0.01% 1807

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

KLP Kapitalforvaltning's RCUS Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Arcus Biosciences (RCUS) position steady in Q2 2026 at 19,300 shares worth $595K. The position accounts for ﹤0.01% of the portfolio, ranked #1435.

KLP Kapitalforvaltning first reported a position in RCUS in Q4 2024 and has held it in 7 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • KLP Kapitalforvaltning held 19,300 shares of Arcus Biosciences worth $595K as of Q2 2026.
  • KLP Kapitalforvaltning left its Arcus Biosciences share count unchanged in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1435 holding.
  • KLP Kapitalforvaltning first reported a position in Arcus Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.